{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"neuronal-ceroid-lipofuscinosis-7","columns":[{"countQualifier":"Onset group unspecified","gene":"MFSD8","key":"population-1913824ed7d4e825b5bb","label":"CLN7","mondoId":"MONDO:0012588","onsetQualifier":null,"originColumnKey":"MONDO:0012588","originalViews":[{"key":"MONDO:0012588","label":"CLN7","scopeLabel":"Genetic form","sourceScope":null}],"recordKeys":["01158190b3e7f66dbe0f902313bb59aa4472ea1664194c6b5aab7a8b8628cc83","0c18ea608cdc794bd524d8e6d40082d85fe263fdfa1cf40a5d34dcf5bfa2959b","0ec535d02d2410cfbfc83d87fb1b0663de8e287507ba334e9fd876b94556de3b","227ff2fcd200565bd2e5420411056c1aeca4099efa586a5784a2c58cb8a8429a","315ffe89130efef42567ff3c45326fbb937877098286c78c8218355fad7efa4b","3165f57cc461da29092d969f0d8282043e663ed3dc087abcb83bf745e901af7f","3b0ea65b90d2f14855323f80e72aad0a8582226d37af5f89ff566baea561ca28","541935290454ee27f6b347e45b03f0622922c7dbef8ffc91baaf9562473bd5e1","705dbdb556021fafbb422d46200238a9c1d855aef0d35a0a2a6ae847513266ef","747143a16b4fdd3ae8ce1a752a00f870543685630583024a7abd7b9a0fb14788","ab3f49d1fd3849353d3ec42c38b43cf0d6cc1d2a8c9e5f2171263c5f3b6eaec7","c71cc50895691941e56dd5d6fae9c66b9f8dbcb7518ac893d25046440099cd4e","cff84f2572f834124badedfc956f4e94d9967c175af24f236ff9666928f6c284","f4fcef8e3f3e97a5e7a6748e41019bd621fdcfaae63766ed26807dcdb25b3cd2","f83eeecc56c13e6551e9885976350f9c30e59147ac8a0f8be9cab62e9eb0b1fb"],"recordQualifiers":{},"scopeLabel":"Genetic form","sourceIds":["OMIM:610951"],"sourceScope":null}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-1913824ed7d4e825b5bb"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001251","HP:0000618","HP:0001272","HP:0002059","HP:0000750","HP:0002353","HP:0002123"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"omim":14,"published":1}},"features":[{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000618","label":"Blindness","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":true},{"hpoId":"HP:0002353","label":"EEG abnormality","primary":true},{"hpoId":"HP:0002123","label":"Generalized myoclonic seizure","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0002180","label":"Neurodegeneration","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000580","label":"Pigmentary retinopathy","primary":false},{"hpoId":"HP:0000488","label":"Retinopathy","primary":false},{"hpoId":"HP:0002360","label":"Sleep disturbance","primary":false},{"hpoId":"HP:0000572","label":"Visual loss","primary":false}],"ledeHtml":"CLN7 disease is an inherited disorder that primarily affects the nervous system. The signs and symptoms of this condition typically begin between ages 2 and 7. The initial features are usually vision loss and problems with movement that might seem like clumsiness. Additional signs and symptoms of CLN7 disease include muscle twitches (myoclonus), difficulty coordinating movements (ataxia), recurrent seizures (epilepsy), and speech impairment. Mental functioning and motor skills (such as sitting and walking) decline with age. Individuals with CLN7 disease typically do not survive past their teens.","mondoId":"MONDO:0012588","node":{"canonicalSlug":"neuronal-ceroid-lipofuscinosis-7","comparisons":[{"documentSha256":"feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069","key":"legacy-cln","kind":"legacy","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cln.feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069.json"},{"documentSha256":"df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3","key":"expanded-cln","kind":"expanded","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012188","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295","MONDO:0017809","MONDO:0019260","MONDO:0019261","MONDO:0019262","MONDO:0030947","MONDO:0850001"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-df7e5010cb40de30aba1.df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Mutations in the MFSD8 gene cause CLN7 disease. The MFSD8 gene provides instructions for making a protein whose function is unknown. The MFSD8 protein is embedded in the membrane of cell compartments called lysosomes, which digest and recycle different types of molecules. Based on the structure of the protein, MFSD8 probably transports molecules across the lysosomal membrane, but the specific molecules it moves have not been identified.","MFSD8 gene mutations likely lead to the production of a protein with altered structure or function. It is unclear how an altered MFSD8 protein leads to the severe neurological features of CLN7 disease. CLN7 disease, like other NCLs, is characterized by the accumulation of proteins and other substances in lysosomes. These accumulations occur in cells throughout the body; however, nerve cells seem to be particularly vulnerable to their effects. These accumulations can cause cell damage leading to cell death. Individuals with CLN7 disease have gradual nerve cell loss in certain parts of the brain, which likely leads to the signs and symptoms of this condition."],"causesUrl":"https://medlineplus.gov/genetics/condition/cln7-disease/#causes","contentForm":"summary","matchMethod":"reviewed-binding","name":"CLN7 disease","paragraphs":["CLN7 disease is an inherited disorder that primarily affects the nervous system. The signs and symptoms of this condition typically begin between ages 2 and 7. The initial features are usually vision loss and problems with movement that might seem like clumsiness. Additional signs and symptoms of CLN7 disease include muscle twitches (myoclonus), difficulty coordinating movements (ataxia), recurrent seizures (epilepsy), and speech impairment. Mental functioning and motor skills (such as sitting and walking) decline with age. Individuals with CLN7 disease typically do not survive past their teens.","CLN7 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), which may also be collectively referred to as Batten disease. All these disorders affect the nervous system and typically cause worsening problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation \"CLN,\" meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype."],"reviewed":"2016-12","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/cln7-disease"},"ownColumnKeys":["population-1913824ed7d4e825b5bb"],"publication":"published","relationships":[{"kind":"parent","label":"late infantile neuronal ceroid lipofuscinosis","mondoId":"MONDO:0015674","slug":"late-infantile-neuronal-ceroid-lipofuscinosis"},{"kind":"parent","label":"neuronal ceroid lipofuscinosis","mondoId":"MONDO:0016295","slug":"cln"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/cln7-disease"}],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/1220","pageMondoId":"MONDO:0012588","source":"GARD","name":"Neuronal ceroid lipofuscinosis 7","url":"https://rarediseases.info.nih.gov/diseases/1220","relationToPage":"same-condition","coveredMondoIds":["MONDO:0012588"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:38:27Z","upstream":"GARD:0001220","rawAttribution":"MONDO:0012588","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"reported","key":"01158190b3e7f66dbe0f902313bb59aa4472ea1664194c6b5aab7a8b8628cc83","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002353","is_excluded":false,"label":"EEG abnormality","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0c18ea608cdc794bd524d8e6d40082d85fe263fdfa1cf40a5d34dcf5bfa2959b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0ec535d02d2410cfbfc83d87fb1b0663de8e287507ba334e9fd876b94556de3b","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000618","is_excluded":false,"label":"Blindness","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"227ff2fcd200565bd2e5420411056c1aeca4099efa586a5784a2c58cb8a8429a","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"315ffe89130efef42567ff3c45326fbb937877098286c78c8218355fad7efa4b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3165f57cc461da29092d969f0d8282043e663ed3dc087abcb83bf745e901af7f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002180","is_excluded":false,"label":"Neurodegeneration","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3b0ea65b90d2f14855323f80e72aad0a8582226d37af5f89ff566baea561ca28","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"541935290454ee27f6b347e45b03f0622922c7dbef8ffc91baaf9562473bd5e1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"705dbdb556021fafbb422d46200238a9c1d855aef0d35a0a2a6ae847513266ef","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"747143a16b4fdd3ae8ce1a752a00f870543685630583024a7abd7b9a0fb14788","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000488","is_excluded":false,"label":"Retinopathy","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ab3f49d1fd3849353d3ec42c38b43cf0d6cc1d2a8c9e5f2171263c5f3b6eaec7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002123","is_excluded":false,"label":"Generalized myoclonic seizure","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c71cc50895691941e56dd5d6fae9c66b9f8dbcb7518ac893d25046440099cd4e","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000580","is_excluded":false,"label":"Pigmentary retinopathy","onset_id":null,"reference":"PMID:19277732","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"cff84f2572f834124badedfc956f4e94d9967c175af24f236ff9666928f6c284","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f4fcef8e3f3e97a5e7a6748e41019bd621fdcfaae63766ed26807dcdb25b3cd2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f83eeecc56c13e6551e9885976350f9c30e59147ac8a0f8be9cab62e9eb0b1fb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610951","disease_name":"Ceroid lipofuscinosis, neuronal, 7","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"OMIM:610951","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln7-disease\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1220\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012588\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>reviewed-binding</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>CLN7 disease is an inherited disorder that primarily affects the nervous system. The signs and symptoms of this condition typically begin between ages 2 and 7. The initial features are usually vision loss and problems with movement that might seem like clumsiness. Additional signs and symptoms of CLN7 disease include muscle twitches (myoclonus), difficulty coordinating movements (ataxia), recurrent seizures (epilepsy), and speech impairment. Mental functioning and motor skills (such as sitting and walking) decline with age. Individuals with CLN7 disease typically do not survive past their teens.</p><p>CLN7 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), which may also be collectively referred to as Batten disease. All these disorders affect the nervous system and typically cause worsening problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation &quot;CLN,&quot; meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln7-disease\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Mutations in the MFSD8 gene cause CLN7 disease. The MFSD8 gene provides instructions for making a protein whose function is unknown. The MFSD8 protein is embedded in the membrane of cell compartments called lysosomes, which digest and recycle different types of molecules. Based on the structure of the protein, MFSD8 probably transports molecules across the lysosomal membrane, but the specific molecules it moves have not been identified.</p><p>MFSD8 gene mutations likely lead to the production of a protein with altered structure or function. It is unclear how an altered MFSD8 protein leads to the severe neurological features of CLN7 disease. CLN7 disease, like other NCLs, is characterized by the accumulation of proteins and other substances in lysosomes. These accumulations occur in cells throughout the body; however, nerve cells seem to be particularly vulnerable to their effects. These accumulations can cause cell damage leading to cell death. Individuals with CLN7 disease have gradual nerve cell loss in certain parts of the brain, which likely leads to the signs and symptoms of this condition.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln7-disease/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"neuronal-ceroid-lipofuscinosis-7","sourceDocuments":[{"name":"MedlinePlus: CLN7 disease","reviewed":"2016-12","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/cln7-disease"},{"name":"GARD: Neuronal ceroid lipofuscinosis 7","reviewed":null,"source_release":"2026-10-25T03:38:27Z","url":"https://rarediseases.info.nih.gov/diseases/1220"},{"name":"MONDO: neuronal ceroid lipofuscinosis 7","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012588"}],"sourceNote":"","synonyms":["ceroid lipofuscinosis, neuronal, 7","ceroid lipofuscinosis, neuronal, type 7","CLN7","CLN7 disease","CLN7 disease, late infantile","MFSD8 neuronal ceroid lipofuscinosis","neuronal ceroid lipofuscinosis 7","neuronal ceroid lipofuscinosis caused by mutation in MFSD8","neuronal ceroid lipofuscinosis type 7"],"takeawayHtml":"","title":"neuronal ceroid lipofuscinosis 7"},"schemaVersion":1}
